The DNA data of millions of people who used 23andMe’s services won’t be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth of genetic data, to a nonprofit led by co-founder Anne Wojcicki.
biotechnology
Posted inNPR
50 years after a seminal conference, big questions about biotechnology remain
In 1975, researchers met to discuss the emerging field of biotechnology. The issues surrounding the field today are familiar.
